Prolonged-release fampridine: a guide to its use in multiple sclerosis in the EU Katherine A. Lyseng-Williamson Adis Drug Clinical Q&A 18 December 2012 Pages: 1 - 4
Current evidence supports the use of combination therapy in the management of benign prostatic hyperplasia Disease Management 18 December 2012 Pages: 5 - 8
Early targeted antibacterial therapy is essential when treating invasive group A streptococcal infection Disease Management 18 December 2012 Pages: 9 - 11
Use pharmacological options sparingly and cautiously in children with nocturnal enuresis Disease Management 18 December 2012 Pages: 12 - 14
Rely on clinical experience to help guide treatment selection for primary cicatricial (scarring) alopecias Disease Management 18 December 2012 Pages: 15 - 17
First reports of serious adverse drug reactions in recent weeks Drug Reactions and Interactions 18 December 2012 Pages: 18 - 19
Manage drug-induced parkinsonism through early recognition of the condition and discontinuation of the causative agent Drug Reactions and Interactions 18 December 2012 Pages: 20 - 23
Ban on the use of cannabinoids in all sports during competition is supported by World Anti-Doping Agency criteria Practical Issues and Updates 18 December 2012 Pages: 24 - 26